Natural Products Industry Insider - News
Renaissance Herbs, Glykon Cut Ties
Posted: April 25, 2005
LAS VEGAS—Glykon Technologies Group, based here, announced it terminated its licensing agreement with Renaissance Herbs, which covered uses and delivery systems for (-)-hydroxycitric acid (HCA). The partnership was announced in February 2004 and was terminated as of Feb. 4, 2005. Glykon holds a number of U.S. patents and patents pending as well as proprietary technology relating to HCA’s impact on insulin and blood sugar, bone mineralization and immune function.
Copyright © 2005 by Virgo Publishing.